SCHEMBL22033730

SCHEMBL22033730

[CH2]C([CH2])OC(=O)CCC(=O)CCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
MAPT P10636 4/20 0.51
MAPK1 P28482 2/20 0.51
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 1/20 0.49
PRKCA P17252 1/20 0.45
PRKCE Q02156 1/20 0.45
PRKCQ Q04759 1/20 0.45
PRKCD Q05655 1/20 0.45
DGKA P23743 1/20 0.44
HTR2C P28335 1/20 0.44
TSHR P16473 1/20 0.42
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
MEN1 O00255 1/20 0.42
GMNN O75496 1/20 0.42
HSP90AA1 P07900 1/20 0.42
BLM P54132 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
NR1H4 Q96RI1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22033659 0.93 LMNA (0.44) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL10536564 0.89 LMNA (0.68) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL22077533 0.89 LMNA (0.68) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL22033883 0.83 LMNA (0.40) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL28609770 0.81 MAPT (0.80) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL28617361 0.81 MAPT (0.80) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL22033759 0.81 LMNA (0.37) LMNAMAPTMAPK1ALDH1A1BLM
SCHEMBL28614977 0.81 MAPT (0.80) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL28614879 0.81 MAPT (0.80) LMNAMAPTMAPK1KMT2AALDH1A1
SCHEMBL28605824 0.81 MAPT (0.80) LMNAMAPTMAPK1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3891127-A1 MODIFIED AMINE LIPIDS Intellia Therapeutics, Inc. (US) 2021-10-13 EP disclosed
WO-2020118041-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed